Kritische 8-K Meldungen
| Datum | Meldung | Schwere | Filing | Auszug |
|---|---|---|---|---|
| 06.02.2025 | Item 4.02 — Bilanzkorrekturen | EXTREM | SEC | ELATED TO ACCOUNTANTS AND FINANCIAL STATEMENTS Item 4.02 Non-Reliance on Previously Issued Financial Statements or a R |
| 29.01.2025 | Item 5.02 — Abgang Schlüsselpersonen | HOCH | SEC | TION 5 – CORPORATE GOVERNANCE AND MANAGEMENT Item 5.02 Departure of Directors or Certain Officers; Election of Directo |
| 07.06.2023 | Item 5.02 — Abgang Schlüsselpersonen | HOCH | SEC | TION 5 – CORPORATE GOVERNANCE AND MANAGEMENT Item 5.02 Departure of Directors or Certain Officers; Election of Directo |
| 26.04.2023 | Item 5.02 — Abgang Schlüsselpersonen | HOCH | SEC | ION 5 – CORPORATE GOVERNANCE AND MANAGEMENT Item 5.02 Departure of Directors or Certain Officers; Election of Director |
| 02.02.2023 | Item 5.02 — Abgang Schlüsselpersonen | HOCH | SEC | TION 5 – CORPORATE GOVERNANCE AND MANAGEMENT Item 5.02 Departure of Directors or Certain Officers; Election of Directo |
Stammdaten
Body and Mind Inc. cultivates, processes, distributes, and retails medical and recreational cannabis in Nevada, California, Arkansas, Ohio, and Michigan in the United States. The company offers packaged and grinded flower buds; concentrates; Gpen vaporizers; distillate oil cartridges; and distillate infused edible products. It also produces and sells medical and adultuse recreational marijuana products, such as cannabis flower, oil, extracts, and edibles under the Body and Mind brand name. In addition, the company operates ShowGrow San Diego dispensary; and manages ShowGrow Long Beach dispensary. Further, it produces marijuana extract products, such as distillate oils, ice waxes, dry sifts, shatters, edibles, and topicals. The company was formerly known as Deploy Technologies Inc. and changed its name to Body and Mind Inc. in November 2017. Body and Mind Inc. was incorporated in 1998 and is headquartered in Vancouver, Canada.
Unternehmen & Branche
| Name | BODY & MIND INC. |
|---|---|
| Ticker | BMMJ |
| CIK | 0001715611 |
| Sektor | Healthcare |
| Industrie | Drug Manufacturers - Specialty & Generic |
| SIC | 2834 · Pharmaceutical Preparations |
Wertpapier & Kennzahlen
| CUSIP | – |
|---|---|
| ISIN | – |
| Typ | – |
| Marktkapitalisierung | 14.769 USD |
| Beta | -0,60 |
| Dividendenrendite | 0,00 % |
Externe Quellen: SEC EDGAR » · FMP-Profil » · Yahoo Finance »
Finanzkennzahlen (SEC XBRL)
| Periode | Filing | Umsatz | Nettoergebnis | EPS | Aktiva | Eigenkapital |
|---|---|---|---|---|---|---|
| 2024-04-30 | 10-Q | 4,406,132 | -2,538,190 | 16,187,375 | -13,090,169 | |
| 2024-01-31 | 10-Q | 4,428,660 | -168,800 | 17,998,419 | -10,869,619 | |
| 2023-10-31 | 10-Q | 5,456,410 | 163,815 | 17,505,161 | -10,524,458 | |
| 2023-07-31 | 10-K | 22,819,983 | -20,566,354 | 21,209,780 | -10,274,746 | |
| 2023-04-30 | 10-Q | 4,171,339 | -3,608,772 | 32,611,987 | 746,798 | |
| 2023-01-31 | 10-Q | 4,433,607 | -2,741,048 | 32,593,897 | 4,295,675 | |
| 2022-10-31 | 10-Q | 5,848,686 | -2,952,795 | 28,996,430 | 6,537,966 | |
| 2022-07-31 | 10-K | 23,372,823 | -28,228,104 | 31,025,863 | 9,630,409 | |
| 2022-04-30 | 10-Q | 7,876,674 | -2,462,103 | 52,991,199 | 29,931,125 | |
| 2022-01-31 | 10-Q | 8,046,526 | -2,722,548 | 53,930,777 | 32,440,847 | |
| 2021-10-31 | 10-Q | 7,570,816 | -677,254 | 48,984,093 | 34,401,949 | |
| 2021-07-31 | 10-K | 26,900,869 | -1,976,461 | 48,125,811 | 34,324,123 | |
| 2021-04-30 | 10-Q | 7,156,016 | -251,723 | 42,210,400 | 32,890,683 | |
| 2021-01-31 | 10-Q | 6,315,411 | -1,147,100 | 41,443,501 | 32,710,044 | |
| 2020-10-31 | 10-Q | 5,294,358 | -778,367 | 40,571,604 | 33,378,852 | |
| 2020-07-31 | 10-K | 6,232,521 | -4,598,389 | 38,799,268 | 33,304,449 | |
| 2020-04-30 | 10-Q | 1,052,306 | -1,156,578 | 39,323,778 | 34,479,353 | |
| 2020-01-31 | 10-Q | 1,572,284 | -1,235,352 | 38,815,625 | 34,713,963 |
Fondsaktivität (Vorquartalsvergleich)
Insider-Transaktionen (12 Monate)
Top-Fondshalter
Keine Fondsdaten zu dieser Aktie vorhanden.